1998•Unpublished venueRequires access

Delivery Systems for Gene Therapy: Adeno‐Associated Virus

Gabriele Kroner‐Lux, Christopher Walsh, Richard Jude Samulski

Abstract

The purpose of this chapter is to provide an overview of recombinant adeno-associated virus (rAAV) vectors and the current “state of the art” of their potential utility in gene therapy of hematopoietic disorders. The authors briefly review AAV biology and genetics and suggest more general reviews about AAV. The basic requirements that need to be fulfilled for gene therapy as treatment of hematopoietic disorders are presented.

About this research paper

What this paper is about

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Adeno-associated virus, Genetic enhancement, Gene delivery, Virology, Haematopoiesis, Virus, Biology, Medicine